In the literature, the chemosensitivity of pediatric osteosarcomas was also correlated to hypoxic markers, like HIF-1α [21], as well as Wnt-βcatenin pathway [22] or angiogenesis [23]. The gene discussed is HIF1A; the disease is osteosarcoma.